Simple test may predict heart attack risk in mild artery disease
NCT ID NCT00868855
First seen Jun 16, 2026 · Last updated Jun 16, 2026
Summary
This study looked at whether measuring a natural clot-busting substance (t-PA) released from heart arteries can predict future heart problems in people with mild to moderate coronary artery disease. Researchers gave a small dose of bradykinin into the heart artery and measured t-PA levels. The goal was to see if poor t-PA release signals higher risk of major cardiac events. Only 16 people were enrolled before the study ended early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.